These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 19072494)

  • 1. Obsessive-compulsive disorder issues pertinent to women.
    Nestadt G
    Womens Health (Lond); 2008 Jul; 4(4):311-3. PubMed ID: 19072494
    [No Abstract]   [Full Text] [Related]  

  • 2. Anxiety disorders and older women.
    Weissman J; Levine SR
    J Women Aging; 2007; 19(1-2):79-101. PubMed ID: 17588881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychosocial treatment for obsessive-compulsive disorder.
    Munford PR; Hand I; Liberman RP
    Psychiatry; 1994 May; 57(2):142-52. PubMed ID: 7938333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practice guideline for the treatment of patients with obsessive-compulsive disorder.
    Koran LM; Hanna GL; Hollander E; Nestadt G; Simpson HB;
    Am J Psychiatry; 2007 Jul; 164(7 Suppl):5-53. PubMed ID: 17849776
    [No Abstract]   [Full Text] [Related]  

  • 5. [Obsessive compulsive disorder (OCD)].
    Debabèche C; Muselle A; Servais S; Farcy L; Barbier V; Laloyaux C; Mikolajczak G; Desseilles M
    Rev Med Suisse; 2009 Aug; 5(214):1659-62. PubMed ID: 19772197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavior therapy augments response of patients with obsessive-compulsive disorder responding to drug treatment.
    Tenneij NH; van Megen HJ; Denys DA; Westenberg HG
    J Clin Psychiatry; 2005 Sep; 66(9):1169-75. PubMed ID: 16187776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obsessive-compulsive disorder: unearthing a hidden problem.
    El-Sayegh S; Bea S; Agelopoulos A
    Cleve Clin J Med; 2003 Oct; 70(10):824-5, 829-30, 832-3, passim. PubMed ID: 14621230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obsessive-compulsive disorder.
    Zohar J; Hermesh H
    Isr J Psychiatry Relat Sci; 2008; 45(3):149-50. PubMed ID: 19398818
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder.
    Mataix-Cols D; Rauch SL; Manzo PA; Jenike MA; Baer L
    Am J Psychiatry; 1999 Sep; 156(9):1409-16. PubMed ID: 10484953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up of 85 patients with obsessive-compulsive disorder.
    Orloff LM; Battle MA; Baer L; Ivanjack L; Pettit AR; Buttolph ML; Jenike MA
    Am J Psychiatry; 1994 Mar; 151(3):441-2. PubMed ID: 8109659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of additional behaviour therapy including treatment discontinuation for fluvoxamine non-responders with obsessive-compulsive disorder.
    Nakatani E; Nakagawa A
    Psychother Psychosom; 2008; 77(6):393-4. PubMed ID: 18716426
    [No Abstract]   [Full Text] [Related]  

  • 12. [The difference between obsessive-compulsive disorder in adolescence and in adults].
    Rabe-Jabłońska J
    Przegl Lek; 2001; 58 Suppl 3():11-4. PubMed ID: 11603169
    [No Abstract]   [Full Text] [Related]  

  • 13. Obsessive-compulsive disorder.
    Veale D; Roberts A
    BMJ; 2014 Apr; 348():g2183. PubMed ID: 24709802
    [No Abstract]   [Full Text] [Related]  

  • 14. Obsessive compulsive disorder is not an anxiety disorder.
    Montgomery SA
    Int Clin Psychopharmacol; 1993 Sep; 8 Suppl 1():57-62. PubMed ID: 8254154
    [No Abstract]   [Full Text] [Related]  

  • 15. Obsessive compulsive disorder.
    Soomro GM
    Clin Evid; 2002 Jun; (7):896-905. PubMed ID: 12230713
    [No Abstract]   [Full Text] [Related]  

  • 16. Postpartum obsessive-compulsive disorder.
    Speisman BB; Storch EA; Abramowitz JS
    J Obstet Gynecol Neonatal Nurs; 2011; 40(6):680-90. PubMed ID: 22092284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up and predictors of clinical outcome in obsessive-compulsive patients treated with serotonin reuptake inhibitors and behavioral therapy.
    Alonso P; Menchon JM; Pifarre J; Mataix-Cols D; Torres L; Salgado P; Vallejo J
    J Clin Psychiatry; 2001 Jul; 62(7):535-40. PubMed ID: 11488364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on obsessive-compulsive disorder.
    Jenike MA
    Bull Menninger Clin; 2001; 65(1):4-25. PubMed ID: 11280957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of tryptophan depletion on selective serotonin reuptake inhibitor-remitted patients with obsessive compulsive disorder.
    Hood SD; Broyd A; Robinson H; Lee J; Hudaib AR; Hince DA
    J Psychopharmacol; 2017 Dec; 31(12):1615-1623. PubMed ID: 29095069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cognitive-behavior therapy for obsessive-compulsive disorder: a systematic review of the last decade].
    Prazeres AM; Souza WF; Fontenelle LF
    Braz J Psychiatry; 2007 Sep; 29(3):262-70. PubMed ID: 17713699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.